Sign In
Buy ANIX
$3.42
-0.140 (-3.93%)
At Close: Jul 31, 2026
Anixa Biosciences Inc (NASDAQ:ANIX) Sees Significant Increase in Short Interest
05:22am, Monday, 29'th Dec 2025
Anixa Biosciences Inc (NASDAQ: ANIX - Get Free Report) saw a large increase in short interest during the month of December. As of December 15th, there was short interest totaling 795,400 shares, an in
Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
08:45am, Monday, 15'th Dec 2025
SAN JOSE, Calif. , Dec. 15, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today an
Anixa Biosciences Shares Jump Over 15% In After-Hours Trading — Here's Why
04:04am, Friday, 12'th Dec 2025
Anixa Biosciences shares surged in after-hours trading after presenting clinical trial data for its investigational breast cancer vaccine.
Vaccine Was Safe and Well Tolerated at the Maximum Tolerated Dose Results Support Advancement of the Program into Phase 2 Development Combination of Keytruda® and the vaccine generated T cell respons
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
09:00am, Wednesday, 10'th Dec 2025
SAN JOSE, Calif. , Dec. 10, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today an
Anixa Biosciences, Inc. (ANIX) Discusses Differentiated CAR-T Therapy and Breast Cancer Vaccine Clinical Programs Transcript
06:17pm, Monday, 17'th Nov 2025
Anixa Biosciences, Inc. ( ANIX ) Discusses Differentiated CAR-T Therapy and Breast Cancer Vaccine Clinical Programs November 11, 2025 2:00 PM EST Company Participants Amit Kumar - CEO, Chairman & Co-C
SAN JOSE, Calif. , Nov. 17, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today an
Water Tower Research Issues Statement Regarding Technical Interruption During Anixa Biosciences Fireside Chat
11:00am, Wednesday, 12'th Nov 2025
Water Tower Research (WTR) issued the following statement regarding a technical issue that occurred during its recent Fireside Chat with Anixa Biosciences, Inc. (NASDAQ: ANIX), held on Tuesday, Novemb
Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s
09:00am, Wednesday, 12'th Nov 2025
Patent Extends Protection for Novel Vaccine Targeting a Cancer Projected to Strike Nearly 300,000 U.S. Women in 2026 SAN JOSE, Calif. , Nov. 12, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa"
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025
10:30am, Monday, 10'th Nov 2025
SAN JOSE, Calif. , Nov. 10, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today a
Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year?
10:40am, Wednesday, 05'th Nov 2025
Here is how ANIXA BIOSCIENCES INC (ANIX) and Boston Scientific (BSX) have performed compared to their sector so far this year.
Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic
08:55am, Wednesday, 05'th Nov 2025
Completion of key step in IND transfer for upcoming Phase 2 breast cancer vaccine clinical trial SAN JOSE, Calif. , Nov. 5, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NA
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
08:45am, Thursday, 23'rd Oct 2025
SAN JOSE, Calif. , Oct. 23, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ann
Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
08:25am, Monday, 20'th Oct 2025
Expands global intellectual property coverage in markets with high breast cancer incidence New patent will provide IP protection of Breast Cancer Vaccine in China into 2040 SAN JOSE, Calif. , Oct. 20,
Are You Looking for a Top Momentum Pick? Why ANIXA BIOSCIENCES INC (ANIX) is a Great Choice
01:01pm, Friday, 17'th Oct 2025
Does ANIXA BIOSCIENCES INC (ANIX) have what it takes to be a top stock pick for momentum investors? Let's find out.
